Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideo Miyakoshi is active.

Publication


Featured researches published by Hideo Miyakoshi.


Japanese Journal of Cancer Research | 1991

Improvement of Gelatin Particle Agglutination Test for Detection of Anti-HTLV-I Antibody

Ryuichi Fujino; Katsuhito Kawato; Mikio Ikeda; Hideo Miyakoshi; Mikio Mizukoshi; Joko Imai

Partial modifications of antigen components were made to improve the gelatin particle agglutination (PA) test for the detection of antibodies against human T cell leukemia virus type‐I. Envelope glycoproteins prepared by lentil lectin affinity chromatography were further added to the purified viral antigens to be coated on the gelatin particles. Comparative studies with a conventional PA test kit (Serodia ATLA) and indirect immunofluorescence assay showed that the specificity and sensitivity of the new PA test were increased and that abnormal agglutination such as the prozone phenomenon was abolished by this improvement.


International Journal of Immunopharmacology | 1984

Acting mechanisms of Lentinan in human--I. Augmentation of DNA synthesis and immunoglobulin production of peripheral mononuclear cells.

Hideo Miyakoshi; Tadao Aoki

The immunopotentiating activity and acting mechanisms of Lentinan were investigated in the human system, resulting in clarification of the following characteristics. (a) Augmentation of DNA synthesis of peripheral mononuclear cells (PMNC) occurred both in vitro and in vivo by adding or injecting Lentinan, for which the coexistence of T cells, B cells and adherent cells (mainly monocytes) was essential. (b) No additional mitogenic effect of Lentinan was observed when PMNC were incubated with both Lentinan and other mitogens. (c) In vitro production of immunoglobulin by PMNC induced with pokeweed mitogen was enhanced through the inhibition of suppressor T cell activity by Lentinan.


NK Cells and Other Natural Effector Cells | 1982

INTERACTION BETWEEN INTERFERON AND NATURAL KILLER CELLS IN HUMANS AFTER ADMINISTRATION OF IMMUNOMODULATING AGENTS

Tadao Aoki; Hideo Miyakoshi; Yoh Horikawa; Akira Shibata; Yoshitaka Aoyagi; Mikio Mizukoshi

Publisher Summary This chapter focuses on interaction between interferon and natural killer (NK) cells in humans after administration of immunomodulating agents. In a styudy described in the chapter, NK activity was readily enhanced, following an increase in the interferon (IFN) titers by Lentinan administration, whereas no significant activation of NK cells was observed even when IFN titers were elevated by Staphage Lysate (SPL) administration. International units of IFN in the body fluid were determined by measuring its inhibitory activity against cytopathic effects of vesicular stomatitis virus (VSV). By sequential measurements of NK activity and IFN titers after Lentinan administration, the peaks of IFN appeared at 12–24 h and NK activity gradually increased in inverse proportion to a decrease in IFN titers, peaking at 24–48 h. To interpret dissociation between the peaks of IFN titers and NK activity, it would be one possible explanation that IFN-activated NK cells gathered and infiltrated into the malignant tissues just after the IFN production by Lentinan administration, resulting in no detection of effective NK cells in the peripheral blood. It seems most likely that this IFN or IFN-like substance produced by SPL affects virus replication but does not activate NK cells.


Clinical Immunology and Immunopathology | 1993

Low NK syndrome and its relationship to chronic fatigue syndrome

Tadao Aoki; Hideo Miyakoshi; Yoshimaru Usuda; Ronald B. Herberman


International Journal of Immunopharmacology | 1984

Acting mechanisms of lentinan in human—II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer

Hideo Miyakoshi; Tadao Aoki; Mikio Mizukoshi


International Journal of Cancer | 1984

In vitro antibody‐dependent cellular cytotoxicity against human T‐cell leukemia/lymphoma virus (HTLV)‐producing cells

Hideo Miyakoshi; Hiroko Koide; Tadao Aoki


International Journal of Cancer | 1984

Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells

Tadao Aoki; Chuya Hamada; Shigeko Ohno; Hideo Miyakoshi; Hiroko Koide; Marjorie Robert-Guroff; Robert C. Ting; Robert C. Gallo


International Journal of Cancer | 1985

Seroepidemilogy of human T‐lymphotropic retrovirus type I (HTLV‐I) in residents of niigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme‐linked immunosorbent assay

Tadao Aoki; Hideo Miyakoshi; Hiroko Koide; Tsutomu Yoshida; Hiroshi Ishikawa; Yuji Sugisaki; Mikio Mizukoshi; Kazue Tamura; Hirondo Misawa; Chuya Hamada; Robert C. Ting; Marjorie Robert-Guroff; Robert C. Gallo


The Lancet | 1984

ANTIBODIES TO HTLV I AND III IN SERA FROM TWO JAPANESE PATIENTS, ONE WITH POSSIBLE PRE-AIDS

Tadao Aoki; Hideo Miyakoshi; Yoshimaru Usuda; Jean-Claude Chermann; Francois Barré-Sinoussi; RobertC. Ting; Robert C. Gallo


Archive | 1994

L-cystein, L-cystine or L-glutamine as a supplementary therapeutic agent for the treatment of immunodeficiency syndrome.

Tadao Aoki; Hideo Miyakoshi

Collaboration


Dive into the Hideo Miyakoshi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert C. Ting

National University of Singapore

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge